Funder: Dept. of the Army -- USAMRAA
Due Dates: September 3, 2026 (Regulatory submission, if IND/IDE required) | September 15, 2026 (Pre-Application/Letter of Intent) | October 1, 2026 (Full Application) | October 6, 2026 (End of Verification Period)
Funding Amounts: Up to $2.8M total costs per award over 4 years; ~2 awards expected; $5.6M total program funding.
Summary: Supports rapid implementation of clinical trials with high impact on ovarian cancer treatment or management.
Key Information: Submission of a Letter of Intent is required before full application; IND/IDE must be submitted by September 3, 2026 if applicable.